Inhalation Anesthesia Market Report by Product (Desflurane, Sevoflurane, Isoflurane, and Others), Application (Induction, Maintenance), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032
The global inhalation anesthesia market size reached US$ 1.60 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.16 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032. The increasing prevalence of chronic medical disorders, collaborations between pharmaceutical companies, medical device manufacturers, and healthcare institutions, and the rising investments by governments and private healthcare providers in state-of-the-art equipment are some of the major factors propelling the market.
Inhalation Anesthesia Market Analysis:
Continual Advancements in Anesthetic Agents and Delivery Systems
Pharmaceutical companies and medical device manufacturers are heavily investing in research and development to create more effective and safer anesthetic gases and vapors. These innovations aim to enhance patient outcomes by reducing the risk of adverse effects and improving the overall anesthesia experience. Newer agents are being developed with improved pharmacokinetic profiles, enabling faster induction and emergence from anesthesia, thus shortening the time patients spend in the operating room. Furthermore, the development of sophisticated delivery systems, including precise vaporizers and monitoring technologies, ensures accurate administration and titration of anesthetic agents, minimizing the chances of over or under dosing. These advancements not only contribute to better patient care but also attract healthcare providers to adopt these modern solutions, thus catalyzing the growth of the inhalation anesthesia market.
Rising Surgical Procedures and Patient Volume
Population growth, often accompanied by an aging demographic, directly correlates with a heightened demand for surgical procedures. The elderly population tends to require more medical interventions due to age-related ailments, such as cardiovascular diseases, joint replacements, and cancer treatments. Consequently, surgical specialties such as orthopedics, cardiology, oncology, and general surgery have seen a rise in demand. Inhalation anesthesia proves to be a preferred option for these procedures due to its rapid onset and controllable depth of sedation. It offers a balance between ensuring patient’s unconsciousness and maintaining their physiological stability. Furthermore, the expansion of medical knowledge and technology has broadened the spectrum of feasible surgical interventions. Minimally invasive procedures, robotics-assisted surgeries, and other innovative techniques have emerged, allowing for safer and quicker interventions.
Expansion of Ambulatory Surgical Centers
ASCs offer numerous advantages, such as cost-effectiveness, shorter patient stays, and reduced risk of hospital-acquired infections. Inhalation anesthesia aligns well with the requirements of ASCs due to its rapid onset and quick recovery profile. Patients undergoing procedures at ASCs often prefer inhalation anesthesia as it allows them to return to their daily activities more swiftly. Moreover, inhalation anesthesia's ability to minimize post-operative nausea and vomiting is particularly valuable in an outpatient setting. As the number of ASCs grows to accommodate the increasing demand for outpatient surgeries, the demand for inhalation anesthesia is expected to witness a significant rise. This trend also encourages manufacturers to develop more portable and user-friendly anesthesia delivery systems tailored to the unique needs of ASCs.
Inhalation Anesthesia Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global inhalation anesthesia market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.
Breakup by Product:
The report has provided a detailed breakup and analysis of the market based on the product. This includes desflurane, sevoflurane, isoflurane, and others. According to the report, sevoflurane represented the largest segment.
Sevoflurane's popularity is largely due to its favorable pharmacokinetic profile. With its rapid induction and emergence characteristics, sevoflurane enables anesthesiologists to guide patients swiftly and smoothly into and out of anesthesia. This not only enhances operational efficiency in medical settings but also ensures that patients experience minimal delay in the start and conclusion of surgical procedures. Moreover, sevoflurane's low blood-gas solubility allows for rapid equilibration between the lungs and the bloodstream, translating into quicker adjustments in the depth of anesthesia and the potential for faster recoveries. Sevoflurane's reduced likelihood of causing organ toxicity or compromising vital functions offers a degree of reassurance to both medical professionals and patients. This safety aspect has been pivotal in cementing sevoflurane's role as a cornerstone of inhalation anesthesia practice, particularly in paediatric and geriatric populations where safety is of paramount concern.
Breakup by Application:
The report has provided a detailed breakup and analysis of the market based on the application. This includes induction and maintenance. According to the report, maintenance represented the largest segment.
The prominence of the maintenance phase is attributed to its role in ensuring patient comfort, surgical precision, and optimal outcomes. Once the patient is induced into anesthesia and the initial surgical incisions are made, maintaining the appropriate anesthetic depth becomes paramount. Anesthesia providers carefully titrate inhalation anesthetic agents to balance the patient's need for complete insensitivity to pain while avoiding over-sedation, which could lead to complications or lengthened recovery times. This dynamic balance requires continuous monitoring and adjustment throughout the procedure, highlighting the importance of skilled anesthesiologists. Moreover, the maintenance phase is directly linked to surgical efficacy and precision. Surgeons rely on patients being adequately anesthetized and immobilized to perform delicate procedures with accuracy. Any fluctuation in the anesthesia depth during the maintenance phase could lead to patient movement or awareness, potentially compromising the surgery's success.
Breakup by End User:
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.
Hospitals offer a diverse range of medical services, encompassing routine surgeries, emergency interventions, and specialized procedures across various medical specialties. The sheer volume and variety of surgical interventions conducted in hospitals create a substantial demand for anesthesia services, and inhalation anesthesia, with its ability to provide rapid induction and adjustable sedation levels, aligns seamlessly with the dynamic environment of hospital operating rooms. Additionally, hospitals provide a comprehensive infrastructure for anesthesia administration and patient care. They possess well-equipped operating suites, sophisticated monitoring systems, and experienced anesthesia teams capable of managing a wide spectrum of cases. This robust setup allows hospitals to efficiently manage the complexities associated with different surgeries, including those requiring inhalation anesthesia. Furthermore, the presence of specialized units within hospitals, such as pediatric and cardiac surgery departments, highlights the versatility of inhalation anesthesia across diverse patient populations and procedural requirements.
Breakup by Region:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America is characterized by its emphasis on medical advancements and innovation. The presence of renowned research institutions, academic medical centers, and cutting-edge pharmaceutical companies fosters an environment conducive to the development of new anesthetic agents, delivery methods, and monitoring technologies. This commitment to innovation not only enhances patient care but also attracts healthcare professionals to adopt state-of-the-art anesthesia practices, including inhalation anesthesia techniques. The region's regulatory landscape and adherence to stringent safety standards further contribute to its dominance. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) play a pivotal role in ensuring the safety and efficacy of anesthesia agents and equipment. This rigorous oversight augments the confidence of healthcare providers and patients in the use of inhalation anesthesia, solidifying North America's position as a leader in the field. Also, North America's focus on medical education and training ensures that anesthesia providers are well-equipped to administer inhalation anesthesia safely and efficiently.
Competitive Landscape:
Pharmaceutical and medical device companies are heavily investing in research and development to create advanced anesthetic agents, delivery systems, and monitoring technologies. Moroever, companies are frequently introducing new inhalation anesthesia products and equipment to cater to the evolving needs of healthcare providers and patients. These products often incorporate the latest technological advancements, such as more precise vaporizers, integrated monitoring systems, and user-friendly interfaces. Additionally, leading players are focusing on developing innovative technologies that enhance the administration and monitoring of inhalation anesthesia. This includes the integration of electronic medical records (EMR) systems, real-time data analysis, and remote monitoring capabilities to ensure optimal patient care and safety. Additionally, numerous companies are providing training and educational programs to healthcare professionals, including anesthesiologists, nurse anaesthetists, and operating room staff. These programs help ensure that healthcare providers are well-versed in the latest techniques, technologies, and safety measures related to inhalation anesthesia.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
1. What was the size of the global inhalation anesthesia market in 2023?
2. What is the expected growth rate of the global inhalation anesthesia market during 2024-2032?
3. What are the key factors driving the global inhalation anesthesia market?
4. What has been the impact of COVID-19 on the global inhalation anesthesia market?
5. What is the breakup of the global inhalation anesthesia market based on the product?
6. What is the breakup of the global inhalation anesthesia market based on the application?
7. What is the breakup of the global inhalation anesthesia market based on the end user?
8. What are the key regions in the global inhalation anesthesia market?
9. Who are the key players/companies in the global inhalation anesthesia market?
Inhalation Anesthesia Market Analysis:
- Market Growth and Size: The market is witnessing steady growth, which can be attributed to increasing surgical procedures worldwide and advancements in healthcare infrastructure. In addition, the rising demand for anesthesia in various surgical procedures is propelling the inhalation anesthesia market growth.
- Major Market Drivers: The growing prevalence of chronic diseases, expanding geriatric population, and rising awareness about the benefits of inhalation anesthesia in surgeries are some of the key factors driving the market. Additionally, technological advancements in anesthesia delivery systems and the introduction of new anesthetic agents are stimulating the market growth.
- Key Market Trends: Inhalation anesthesia Industry trends include the increasing adoption of inhalation anesthesia in ambulatory surgical centers due to its advantages, such as rapid onset, easy administration, and faster recovery. Moreover, there is a shift towards the development of eco-friendly anesthetic agents and delivery systems to minimize environmental impact.
- Geographical Trends: North America leads the market owing to its well-established healthcare infrastructure, high surgical procedure rates, and robust research and development (R&D) activities. However, Asia Pacific is emerging as a fast-growing market, driven by rising healthcare expenditures, improving healthcare facilities, and a large patient pool.
- Competitive Landscape: The market is characterized by intense competition among key players. They are focusing on strategic initiatives, such as mergers and acquisitions (M&A), product launches, and collaborations, to strengthen their market position and expand their product portfolios.
- Challenges and Opportunities: While the market faces challenges, such as stringent regulatory framework governing the approval and commercialization of anesthesia drugs and devices, it also encounters opportunities in in emerging markets due to the increasing demand for minimally invasive (MI) surgeries and ongoing research activities on novel anesthetic agents and delivery methods.
Continual Advancements in Anesthetic Agents and Delivery Systems
Pharmaceutical companies and medical device manufacturers are heavily investing in research and development to create more effective and safer anesthetic gases and vapors. These innovations aim to enhance patient outcomes by reducing the risk of adverse effects and improving the overall anesthesia experience. Newer agents are being developed with improved pharmacokinetic profiles, enabling faster induction and emergence from anesthesia, thus shortening the time patients spend in the operating room. Furthermore, the development of sophisticated delivery systems, including precise vaporizers and monitoring technologies, ensures accurate administration and titration of anesthetic agents, minimizing the chances of over or under dosing. These advancements not only contribute to better patient care but also attract healthcare providers to adopt these modern solutions, thus catalyzing the growth of the inhalation anesthesia market.
Rising Surgical Procedures and Patient Volume
Population growth, often accompanied by an aging demographic, directly correlates with a heightened demand for surgical procedures. The elderly population tends to require more medical interventions due to age-related ailments, such as cardiovascular diseases, joint replacements, and cancer treatments. Consequently, surgical specialties such as orthopedics, cardiology, oncology, and general surgery have seen a rise in demand. Inhalation anesthesia proves to be a preferred option for these procedures due to its rapid onset and controllable depth of sedation. It offers a balance between ensuring patient’s unconsciousness and maintaining their physiological stability. Furthermore, the expansion of medical knowledge and technology has broadened the spectrum of feasible surgical interventions. Minimally invasive procedures, robotics-assisted surgeries, and other innovative techniques have emerged, allowing for safer and quicker interventions.
Expansion of Ambulatory Surgical Centers
ASCs offer numerous advantages, such as cost-effectiveness, shorter patient stays, and reduced risk of hospital-acquired infections. Inhalation anesthesia aligns well with the requirements of ASCs due to its rapid onset and quick recovery profile. Patients undergoing procedures at ASCs often prefer inhalation anesthesia as it allows them to return to their daily activities more swiftly. Moreover, inhalation anesthesia's ability to minimize post-operative nausea and vomiting is particularly valuable in an outpatient setting. As the number of ASCs grows to accommodate the increasing demand for outpatient surgeries, the demand for inhalation anesthesia is expected to witness a significant rise. This trend also encourages manufacturers to develop more portable and user-friendly anesthesia delivery systems tailored to the unique needs of ASCs.
Inhalation Anesthesia Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global inhalation anesthesia market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.
Breakup by Product:
- Desflurane
- Sevoflurane
- Isoflurane
- Others
The report has provided a detailed breakup and analysis of the market based on the product. This includes desflurane, sevoflurane, isoflurane, and others. According to the report, sevoflurane represented the largest segment.
Sevoflurane's popularity is largely due to its favorable pharmacokinetic profile. With its rapid induction and emergence characteristics, sevoflurane enables anesthesiologists to guide patients swiftly and smoothly into and out of anesthesia. This not only enhances operational efficiency in medical settings but also ensures that patients experience minimal delay in the start and conclusion of surgical procedures. Moreover, sevoflurane's low blood-gas solubility allows for rapid equilibration between the lungs and the bloodstream, translating into quicker adjustments in the depth of anesthesia and the potential for faster recoveries. Sevoflurane's reduced likelihood of causing organ toxicity or compromising vital functions offers a degree of reassurance to both medical professionals and patients. This safety aspect has been pivotal in cementing sevoflurane's role as a cornerstone of inhalation anesthesia practice, particularly in paediatric and geriatric populations where safety is of paramount concern.
Breakup by Application:
- Induction
- Maintenance
The report has provided a detailed breakup and analysis of the market based on the application. This includes induction and maintenance. According to the report, maintenance represented the largest segment.
The prominence of the maintenance phase is attributed to its role in ensuring patient comfort, surgical precision, and optimal outcomes. Once the patient is induced into anesthesia and the initial surgical incisions are made, maintaining the appropriate anesthetic depth becomes paramount. Anesthesia providers carefully titrate inhalation anesthetic agents to balance the patient's need for complete insensitivity to pain while avoiding over-sedation, which could lead to complications or lengthened recovery times. This dynamic balance requires continuous monitoring and adjustment throughout the procedure, highlighting the importance of skilled anesthesiologists. Moreover, the maintenance phase is directly linked to surgical efficacy and precision. Surgeons rely on patients being adequately anesthetized and immobilized to perform delicate procedures with accuracy. Any fluctuation in the anesthesia depth during the maintenance phase could lead to patient movement or awareness, potentially compromising the surgery's success.
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.
Hospitals offer a diverse range of medical services, encompassing routine surgeries, emergency interventions, and specialized procedures across various medical specialties. The sheer volume and variety of surgical interventions conducted in hospitals create a substantial demand for anesthesia services, and inhalation anesthesia, with its ability to provide rapid induction and adjustable sedation levels, aligns seamlessly with the dynamic environment of hospital operating rooms. Additionally, hospitals provide a comprehensive infrastructure for anesthesia administration and patient care. They possess well-equipped operating suites, sophisticated monitoring systems, and experienced anesthesia teams capable of managing a wide spectrum of cases. This robust setup allows hospitals to efficiently manage the complexities associated with different surgeries, including those requiring inhalation anesthesia. Furthermore, the presence of specialized units within hospitals, such as pediatric and cardiac surgery departments, highlights the versatility of inhalation anesthesia across diverse patient populations and procedural requirements.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America is characterized by its emphasis on medical advancements and innovation. The presence of renowned research institutions, academic medical centers, and cutting-edge pharmaceutical companies fosters an environment conducive to the development of new anesthetic agents, delivery methods, and monitoring technologies. This commitment to innovation not only enhances patient care but also attracts healthcare professionals to adopt state-of-the-art anesthesia practices, including inhalation anesthesia techniques. The region's regulatory landscape and adherence to stringent safety standards further contribute to its dominance. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) play a pivotal role in ensuring the safety and efficacy of anesthesia agents and equipment. This rigorous oversight augments the confidence of healthcare providers and patients in the use of inhalation anesthesia, solidifying North America's position as a leader in the field. Also, North America's focus on medical education and training ensures that anesthesia providers are well-equipped to administer inhalation anesthesia safely and efficiently.
Competitive Landscape:
Pharmaceutical and medical device companies are heavily investing in research and development to create advanced anesthetic agents, delivery systems, and monitoring technologies. Moroever, companies are frequently introducing new inhalation anesthesia products and equipment to cater to the evolving needs of healthcare providers and patients. These products often incorporate the latest technological advancements, such as more precise vaporizers, integrated monitoring systems, and user-friendly interfaces. Additionally, leading players are focusing on developing innovative technologies that enhance the administration and monitoring of inhalation anesthesia. This includes the integration of electronic medical records (EMR) systems, real-time data analysis, and remote monitoring capabilities to ensure optimal patient care and safety. Additionally, numerous companies are providing training and educational programs to healthcare professionals, including anesthesiologists, nurse anaesthetists, and operating room staff. These programs help ensure that healthcare providers are well-versed in the latest techniques, technologies, and safety measures related to inhalation anesthesia.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- Abbvie Inc.
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- Halocarbon Products Corporation
- Hikma Pharmaceuticals PLC
- Lunan Pharmaceutical Group Co. Ltd
- Merck KGaA
- Piramal Enterprises Ltd.
- Troikaa Pharmaceuticals Ltd.
- In May 2023, Piramal Enterprises Ltd collaborated with plus therapeutics to meet increase in investigational drug demand for ongoing and planned clinical trials.
- In April 2023, Baxter International Inc. launched Zosyn Premix. It is indicated for the treatment of multiple infections caused by susceptible bacteria.
- In December 2021, Hikma Pharmaceuticals PLC launched Bupivacaine HCl Injection. Bupivacaine HCl Injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures.
1. What was the size of the global inhalation anesthesia market in 2023?
2. What is the expected growth rate of the global inhalation anesthesia market during 2024-2032?
3. What are the key factors driving the global inhalation anesthesia market?
4. What has been the impact of COVID-19 on the global inhalation anesthesia market?
5. What is the breakup of the global inhalation anesthesia market based on the product?
6. What is the breakup of the global inhalation anesthesia market based on the application?
7. What is the breakup of the global inhalation anesthesia market based on the end user?
8. What are the key regions in the global inhalation anesthesia market?
9. Who are the key players/companies in the global inhalation anesthesia market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL INHALATION ANESTHESIA MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Desflurane
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Sevoflurane
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Isoflurane
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Induction
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Maintenance
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbvie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Baxter International Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Fresenius SE & Co. KGaA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Halocarbon Products Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Hikma Pharmaceuticals PLC
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Lunan Pharmaceutical Group Co. Ltd
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Merck KGaA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Piramal Enterprises Ltd.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Troikaa Pharmaceuticals Ltd
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL INHALATION ANESTHESIA MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Desflurane
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Sevoflurane
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Isoflurane
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Induction
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Maintenance
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbvie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Baxter International Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Fresenius SE & Co. KGaA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Halocarbon Products Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Hikma Pharmaceuticals PLC
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Lunan Pharmaceutical Group Co. Ltd
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Merck KGaA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Piramal Enterprises Ltd.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Troikaa Pharmaceuticals Ltd
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
LIST OF TABLES
Table 1: Global: Inhalation Anesthesia Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Inhalation Anesthesia Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Inhalation Anesthesia Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Inhalation Anesthesia Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Inhalation Anesthesia Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Inhalation Anesthesia Market: Competitive Structure
Table 7: Global: Inhalation Anesthesia Market: Key Players
Table 1: Global: Inhalation Anesthesia Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Inhalation Anesthesia Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Inhalation Anesthesia Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Inhalation Anesthesia Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Inhalation Anesthesia Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Inhalation Anesthesia Market: Competitive Structure
Table 7: Global: Inhalation Anesthesia Market: Key Players
LIST OF FIGURES
Figure 1: Global: Inhalation Anesthesia Market: Major Drivers and Challenges
Figure 2: Global: Inhalation Anesthesia Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Inhalation Anesthesia Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Inhalation Anesthesia Market: Breakup by Product (in %), 2023
Figure 5: Global: Inhalation Anesthesia Market: Breakup by Application (in %), 2023
Figure 6: Global: Inhalation Anesthesia Market: Breakup by End User (in %), 2023
Figure 7: Global: Inhalation Anesthesia Market: Breakup by Region (in %), 2023
Figure 8: Global: Inhalation Anesthesia (Desflurane) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Inhalation Anesthesia (Desflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Inhalation Anesthesia (Sevoflurane) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Inhalation Anesthesia (Sevoflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Inhalation Anesthesia (Isoflurane) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Inhalation Anesthesia (Isoflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Inhalation Anesthesia (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Inhalation Anesthesia (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Inhalation Anesthesia (Induction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Inhalation Anesthesia (Induction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Inhalation Anesthesia (Maintenance) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Inhalation Anesthesia (Maintenance) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Inhalation Anesthesia (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Inhalation Anesthesia (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Inhalation Anesthesia (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Inhalation Anesthesia (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: North America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: North America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: United States: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: United States: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Canada: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Canada: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Asia-Pacific: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Asia-Pacific: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: China: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: China: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Japan: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Japan: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: India: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: India: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Korea: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Korea: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Australia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Australia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Indonesia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Indonesia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Europe: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Europe: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Germany: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Germany: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: France: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: France: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United Kingdom: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United Kingdom: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Italy: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Italy: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Spain: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Spain: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Russia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Russia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Latin America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Latin America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Brazil: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Brazil: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Mexico: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Mexico: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Middle East and Africa: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Middle East and Africa: Inhalation Anesthesia Market: Breakup by Country (in %), 2023
Figure 74: Middle East and Africa: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Inhalation Anesthesia Industry: SWOT Analysis
Figure 76: Global: Inhalation Anesthesia Industry: Value Chain Analysis
Figure 77: Global: Inhalation Anesthesia Industry: Porter's Five Forces Analysis
Figure 1: Global: Inhalation Anesthesia Market: Major Drivers and Challenges
Figure 2: Global: Inhalation Anesthesia Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Inhalation Anesthesia Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Inhalation Anesthesia Market: Breakup by Product (in %), 2023
Figure 5: Global: Inhalation Anesthesia Market: Breakup by Application (in %), 2023
Figure 6: Global: Inhalation Anesthesia Market: Breakup by End User (in %), 2023
Figure 7: Global: Inhalation Anesthesia Market: Breakup by Region (in %), 2023
Figure 8: Global: Inhalation Anesthesia (Desflurane) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Inhalation Anesthesia (Desflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Inhalation Anesthesia (Sevoflurane) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Inhalation Anesthesia (Sevoflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Inhalation Anesthesia (Isoflurane) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Inhalation Anesthesia (Isoflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Inhalation Anesthesia (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Inhalation Anesthesia (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Inhalation Anesthesia (Induction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Inhalation Anesthesia (Induction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Inhalation Anesthesia (Maintenance) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Inhalation Anesthesia (Maintenance) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Inhalation Anesthesia (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Inhalation Anesthesia (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Inhalation Anesthesia (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Inhalation Anesthesia (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: North America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: North America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: United States: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: United States: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Canada: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Canada: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Asia-Pacific: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Asia-Pacific: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: China: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: China: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Japan: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Japan: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: India: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: India: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Korea: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Korea: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Australia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Australia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Indonesia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Indonesia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Europe: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Europe: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Germany: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Germany: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: France: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: France: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United Kingdom: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United Kingdom: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Italy: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Italy: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Spain: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Spain: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Russia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Russia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Latin America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Latin America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Brazil: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Brazil: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Mexico: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Mexico: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Middle East and Africa: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Middle East and Africa: Inhalation Anesthesia Market: Breakup by Country (in %), 2023
Figure 74: Middle East and Africa: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Inhalation Anesthesia Industry: SWOT Analysis
Figure 76: Global: Inhalation Anesthesia Industry: Value Chain Analysis
Figure 77: Global: Inhalation Anesthesia Industry: Porter's Five Forces Analysis
